North Carolina construction worker Derek Barnett, 55, lost more than 70 pounds on a unique nutrition and fitness journey after being diagnosed with liver cancer.
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...
Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Hepatocellular Carcinoma.
Advances in therapy are improving outcomes for patients, but the incidence and mortality rates for hepatocellular carcinoma ...
News Medical on MSN7d
Investigating fatty acid metabolism in hepatocellular carcinoma patientsAnnouncing a new publication for Acta Materia Medica journal. Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the ...
Tevimbra is under clinical development by BeiGene and currently in Phase III for Hepatocellular Carcinoma. According to GlobalData, Phase III drugs for Hepatocellular Carcinoma have a 47% phase ...
Interesting Engineering on MSN9d
Korean researchers find cancer undo button, turn tumor cells to normal onesThis is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback